Burning Rock Biotech (BNR) Other Gross PP&E Adjustments (2021 - 2023)

Burning Rock Biotech has reported Other Gross PP&E Adjustments over the past 3 years, most recently at $72.7 million for Q4 2023.

  • Quarterly results put Other Gross PP&E Adjustments at $72.7 million for Q4 2023, up 7.57% from a year ago — trailing twelve months through Dec 2023 was $72.7 million (up 7.57% YoY), and the annual figure for FY2023 was $73.8 million, up 2.98%.
  • Other Gross PP&E Adjustments for Q4 2023 was $72.7 million at Burning Rock Biotech, up from $67.6 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for BNR hit a ceiling of $72.7 million in Q4 2023 and a floor of $63.4 million in Q4 2021.
  • Median Other Gross PP&E Adjustments over the past 3 years was $67.6 million (2022), compared with a mean of $67.9 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 6.62% in 2022 and later increased 7.57% in 2023.
  • Burning Rock Biotech's Other Gross PP&E Adjustments stood at $63.4 million in 2021, then grew by 6.62% to $67.6 million in 2022, then increased by 7.57% to $72.7 million in 2023.
  • The last three reported values for Other Gross PP&E Adjustments were $72.7 million (Q4 2023), $67.6 million (Q4 2022), and $63.4 million (Q4 2021) per Business Quant data.